Extension Study of Bomedemstat (IMG-7289) in Patients With Myeloproliferative Neoplasms

Conditions:   Thrombocythemia, Essential;   Primary Myelofibrosis Intervention:   Drug: Bomedemstat Sponsor:   Imago BioSciences,Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials